User:lucyyndu447842

Datopotamab Deruxtecan, often abbreviated as DATO, represents a significant advancement in targeted cancer therapy. This new antibody-drug conjugate combines a monoclonal immunoglobulin

https://www.targetmol.com/compound/datopotamab